Daiichi Sankyo approached Mawdsleys’ Pre-Wholesale (MPW) in January 2016; seeking a flexible, cost effective pre-wholesale distributor, that excelled in efficiency.      Actions/Results:   After discussing Daiichi Sankyo’s requirements, MPW successfully delivered an integration of Daiichi Sankyo’s SAP (Systems Applications Products) IT systems and Mawdsleys’ IT software; in turn allowing…

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…